North America Mobile Health (mHealth) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The North America mobile health (mhealth) market is estimated to register a CAGR of 27.5%, over the forecast period.
The studied market was impacted by the pandemic, majorly due to industry closures and supply chain disruptions. The COVID-19 epidemic, however, is probably going to have a comparatively beneficial effect on the market as a whole. Mobile health has become a new rescuer in the fight against infection transmission and for the protection of both patients and front-line staff. The use of smartphones and remote monitoring as part of mobile health solutions has transformed them into essential tools for consultation. The primary cause of it is the widespread use of a two-way approach to patient care by healthcare professionals. Therefore, the rising cases of COVID-19 are expected to increase the mobile health business. Additionally, it is projected that the recent developments in the mobile health (mHealth) sector during the pandemic will significantly affect market growth. For instance, a research study was carried out in the United States from April 18 to May 5, 2020, to look for mHealth apps accessible in the Play Store for Android and the App Store for iOS. The findings of this investigation revealed that more than half of the included mobile applications were legitimate apps maintained by a health authority for the distribution of COVID-19 information. Only 17% of mobile apps offer an online consultation feature, whereas roughly 37.5% and 31.3% of mobile apps include tracing or mapping and home monitoring surveillance functions, respectively. This research showed that there was an increased demand for mHealth apps during the pandemic, which is expected to have a significant impact on the studied market. Thus, owing to the aforesaid factors, the COVID-19 pandemic is expected to have a significant impact on the market studied.
The major factors contributing to the market growth in the region are the growing burden of chronic diseases, such as coronary heart diseases, atrial fibrillation, stroke, and hypertension, supportive government policies toward awareness, high healthcare spending, growing product launches, rising adoption of key strategies such as partnerships and acquisitions, and growing investments. According to the estimates of the American Cancer Society, in 2021, an estimated 1,898,160 new cases of cancer were expected to be diagnosed in the United States. Thus, these patients would require constant monitoring and hence would need a patient-centric healthcare app. Thus, this is expected to increase the market growth. Additionally, nearly half of Americans, including those with hypertension and coronary heart disease, have some form of cardiovascular illness. As per the data from the Centers for Disease Control and Prevention 2020, every year, 805,000 people in the United States have a heart attack, 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Similarly, as stated by the American Heart Association 2021 journal, it is estimated that by the year 2035, more than 130 million adults in the United States will have some type of heart disease. Increasing prevalence of heart disease is expected to create demand for the diagnostic of such disease which is expected to increase market growth. Furthermore, initaitive by the key market players are another factor in market growth. In December 2021, Baxter International Inc. completed the acquisition of Hillrom. Baxter intends to construct a linked system around the patient and their care team using its collective expertise in connectivity technologies and integration, digital health solutions, data visualization, and analytics, therapeutic development, and monitoring and sensing. Thus, such acquisitions will likely increase the country's market growth. Thus, the above-mentioned factors are expected to boost the growth of the market studied in the country.
However, the effectiveness and efficiency of certain devices have been a factor, along with data privacy issues, which hinder the growth of mobile health in the North America region.
Key Market TrendsRemote Patient Monitoring Devices are Estimated to Hold Major Share, Over the Forecast PeriodMobile-Health for monitoring and collecting real-time patient data plays a critical role in managing various vital parameters of the patients for better health outcomes. Remote patient monitoring is a technology that enables patient monitoring outside conventional clinics or hospital settings in a home or remote area. This remote patient monitoring is recognized as a valuable tool for enhancing quality care in disease management. Additionally, several factors influence the differences in chronic diseases newly diagnosed in women and men. The data updated by the government of Canada in December 2021, compared to men the same age, women aged 65+ are more likely to be newly diagnosed with these chronic diseases. And as per the data updated, crude incidence rates per 100,000 persons aged 65 years and older for osteoarthritis, osteoporosis, dementia, asthma, and rheumatoid arthritis in women in Canada were 2,687.2, 2,151.1, 1,488.7, 446.2, and 186.7, respectively. Thus, the incidence of chronic diseases is expected to demand point-of-care diagnosis for faster and more effective treatment. This is expected to drive market growth. New services and product launches enabling healthcare providers and caretakers towards remote patient monitoring are expected to drive segment growth. For instance, in January 2022, OMRON Healthcare globally launched its remote patient monitoring services along with its connected blood pressure monitors and an advanced mobile app, and with this, the company expanded its digital health services to aid consumers on every step of their heart health journey. In September 2021, Mount Sinai Health System launched a comprehensive mobile application for patients called MyMountSinai, and this app provided another access point to care and communication, which enhanced the patient experience. Hence, the afore-said factors are expected to boost segment growth, which is likely to boost the market growth over the forecast period.
United States is Expected to Dominate the Market Over the Forecast PeriodAll medical and public health applications are supported by mobile devices like cell phones, patient monitoring devices, and other wireless devices. The growing advances in mobile technologies and applications, coupled with rising in the new opportunities for the integration of mobile health (mHealth) into existing eHealth services and the continued growth in the coverage of mobile cellular networks in the United States, are expected to boost the growth of the studied segment in the country. As per the American Academy of Family Physicians Fact sheet 2020, due to the outbreak of COVID-19, the Centers for Medicare and Medicaid Services (CMS) broadened access to Medicare telehealth services so that beneficiaries could receive a wider range of services from their doctors without having to travel to a healthcare facility. In addition, in May 2020, the United States government initiated the telehealth and telemedicine tool kit, which provided three main types of virtual services that physicians and other professionals could provide to Medicare medicare telehealth visits, virtual check-ins, and e-visits. These developments are expected to boost the market growth. The continuous product launches with new advancements are boosting the growth of the studied market in the United States. For instance, in May 2020, the United States government initiated the telehealth and telemedicine tool kit, which provided three main types of virtual services that physicians and other professionals could provide to Medicare medicare telehealth visits, virtual check-ins, and e-visits. These developments are expected to boost the market growth. Apart from the new product launches, the initiatives and strategic alliances done by the major players and associations contribute to the studied market's growth. Similarly, in April 2021, the American Health Information Management Association (AHIMA), together with Moxe, a clinical data warehouse focusing on interoperability, AHIMA launched AHIMA dHealth, a mHealth resource and assessment tool for vendors. Thus, due to the above-mentioned factors, the studied market is expected to grow in the United States during the study period.
Competitive LandscapeThe major market players are focusing on better distribution channel as well as reaching out to different hospital and healthcare facilities across different cities and patients, which makes the companies grow in this market. Some of the major players in the market are Boston Scientific Corporation, Koninklijke Philips N.V., Medtronic PLC, BioTelemetry Inc and AT&T Inc among others.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook